CJC-1295 7.5mg / Ipamorelin 15mg – Growth Hormone Secretagogue Research Blend
 
CJC-1295 / Ipamorelin is a high-purity peptide combination designed to investigate the dual-action stimulation of growth hormone pathways in advanced laboratory research settings.
This formulation pairs CJC-1295 (a GHRH analog) with Ipamorelin (a selective GHSR agonist). In experimental models, this synergistic blend is studied for its ability to mimic natural pulsatile growth hormone release by simultaneously stimulating the pituitary gland and inhibiting somatostatin. Researchers utilize this combination to analyze metabolic regulation, cellular repair mechanisms, and the modulation of lean muscle mass and adipose tissue metabolism.
By combining a larger concentration of Ipamorelin with CJC-1295 (without DAC), this blend is optimized for the study of acute endocrine signaling patterns and physiological responses without the prolonged systemic exposure associated with long-acting analogs.
 
High purity (>99% HPLC)
Dual-action formulation (7.5mg CJC-1295 / 15mg Ipamorelin)
Endotoxin tested (<0.079 EU/mL) for high biological safety
Identity confirmed via LC-MS analysis
 
For laboratory research use only. Not for human or veterinary consumption.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.